Fill out the form below to watch the webinar

In this webinar, industry leaders share their assessment of the current status and main challenges facing the T cell therapy manufacturing community. Additionally, lessons learned on transitioning from autologous to allogeneic workflows is discussed, and how this may impact the future of cell therapy manufacturing.

Topics covered:


(*Indicates a mandatory field)